KEAP1 and cancer: The occurrence of the genetic mutations in Nrf2 is documented concerning Loss-of-function (LOF) somatic mutation in the KEAP1 gene, elevating levels of transcription activity in tumor cells, presenting survival benefits to the cancer cells [56].